EpiCast Report: Hyperparathyroidism - Epidemiology Forecast to 2025

2016-12-14
Price :
Published : Dec-2016
No. of Pages : 57
Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 Epidemiology 8
2.1 Disease Background 8
2.2 Risk Factors and Comorbidities 9
2.3 Global Trends 10
2.3.1 Prevalence 11
2.4 Forecast Methodology 12
2.4.1 Sources Used 12
2.4.2 Forecast Assumptions and Methods 16
2.4.3 Sources Not Used 25
2.5 Epidemiological Forecast of HPT (2015-2025) 26
2.5.1 Diagnosed Prevalent Cases 26
2.5.2 Total Prevalent Cases of SHPT 32
2.5.3 Diagnosed Prevalent Cases of THPT 42
2.6 Discussion 45
2.6.1 Epidemiological Forecast Insight 45
2.6.2 Limitations of the Analysis 46
2.6.3 Strengths of the Analysis 47
3 Appendix 48
3.1 Bibliography 48
3.2 About the Authors 52
3.2.1 Epidemiologists 52
3.2.2 Reviewers 53
3.2.3 Global Director of Therapy Analysis and Epidemiology 54
3.3 About GlobalData 55
3.4 About EpiCast 55
3.5 Disclaimer 56

List of Tables
Table 1: Risk Factors and Comorbidities of HPT 10
Table 2: Diagnositc Criteria for PHPT, SHPT, and THPT 13
Table 3: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of PHPT 13
Table 4: 7MM, Sources Used to Forecast the Total Prevalent Cases of SHPT 14
Table 5: 7MM, Sources Used to Forecast the Diagnosed Prevalent Cases of THPT 15
Table 6: 7MM, Sources Used to Forecast the Total Prevalent Cases of CKD 16
Table 7: 7MM, Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 26
Table 8: 7MM, Age-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N (Row %), 2015 28
Table 9: 7MM, Sex-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years N (Row %), 2015 30
Table 10: 7MM Total Prevalent Cases of SHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 33
Table 11: 7MM, Age-Specific Total Prevalent Cases of SHPT, Both Sexes, N (Row %), 2015 34
Table 12: 7MM, Sex-Specific Total Prevalent Cases of SHPT, Ages =20 Years, N (Row %), 2015 36
Table 13: 7MM, SHPT in Pre-Dialysis CKD Total Prevalent Population (Stages 3-5), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 39
Table 14: 7MM, SHPT in Dialysis CKD Total Prevalent Population (Stage 5D), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 41
Table 15: 7MM, Diagnosed Prevalent Cases of THPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 42
Table 16: 7MM, Sex-Specific Diagnosed Prevalent Cases of THPT, Ages =20 Years, N (Row %), 2015 44

List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 27
Figure 2: 7MM, Age-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years, Both Sexes, N, 2015 29
Figure 3: 7MM, Sex-Specific Diagnosed Prevalent Cases of PHPT, Ages =20 Years, 2015 31
Figure 4: 7MM, Age-Standardized Diagnosed Prevalent Cases of PHPT, Ages =20 Years, N, 2015 32
Figure 5: 7MM, Total Prevalent Cases of SHPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 33
Figure 6: 7MM, Age-Specific Total Prevalence of SHPT, Ages =20 Years, Both Sexes, N, 2015 35
Figure 7: 7MM, Sex-Specific Total Prevalent Cases of SHPT, Ages =20 Years, N, 2015 37
Figure 8: 7MM, Age-Standardized Total Prevalent Cases of SHPT, Ages =20 Years, N, 2015 38
Figure 9: 7MM, SHPT in Pre-Dialysis CKD Total Prevalent Population (Stages 3-5), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 40
Figure 10: 7MM, SHPT in Dialysis CKD Total Prevalent Population (Stages 5D), Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 41
Figure 11: 7MM, Diagnosed Prevalent Cases of THPT, Ages =20 Years, Both Sexes, N, Selected Years 2015-2025 43
Figure 12: 7MM, Sex-Specific Diagnosed Prevalent Cases of THPT, Ages =20 Years, N, 2015 45
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData